Myriad Genetics, Inc. (MYGN)
5.66
-0.02
(-0.35%)
USD |
NASDAQ |
Nov 13, 16:00
5.645
-0.02
(-0.27%)
After-Hours: 19:59
Myriad Genetics Net Income (Quarterly) : -43.90M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -43.90M |
| June 30, 2026 | -43.20M |
| March 31, 2026 | -34.10M |
| December 31, 2025 | -7.90M |
| September 30, 2025 | -27.40M |
| June 30, 2025 | -330.50M |
| March 31, 2025 | -0.10M |
| December 31, 2024 | -42.50M |
| September 30, 2024 | -22.10M |
| June 30, 2024 | -36.70M |
| March 31, 2024 | -26.00M |
| December 31, 2023 | -31.20M |
| September 30, 2023 | -61.30M |
| June 30, 2023 | -116.10M |
| March 31, 2023 | -54.70M |
| December 31, 2022 | -42.30M |
| September 30, 2022 | -35.10M |
| June 30, 2022 | -14.10M |
| March 31, 2022 | -20.50M |
| December 31, 2021 | -7.60M |
| September 30, 2021 | 24.60M |
| June 30, 2021 | -4.70M |
| March 31, 2021 | -39.50M |
| June 30, 2020 | -55.50M |
| March 31, 2020 | -115.20M |
| Date | Value |
|---|---|
| December 31, 2019 | -8.30M |
| September 30, 2019 | -20.60M |
| June 30, 2019 | -4.30M |
| March 31, 2019 | 6.90M |
| December 31, 2018 | 2.60M |
| September 30, 2018 | -0.80M |
| June 30, 2018 | 14.50M |
| March 31, 2018 | 9.00M |
| December 31, 2017 | 30.90M |
| September 30, 2017 | 78.70M |
| June 30, 2017 | 12.70M |
| March 31, 2017 | 4.20M |
| December 31, 2016 | 5.90M |
| September 30, 2016 | -1.20M |
| June 30, 2016 | 23.40M |
| March 31, 2016 | 34.50M |
| December 31, 2015 | 30.30M |
| September 30, 2015 | 26.60M |
| June 30, 2015 | 18.70M |
| March 31, 2015 | 21.48M |
| December 31, 2014 | 24.03M |
| September 30, 2014 | 15.98M |
| June 30, 2014 | 33.63M |
| March 31, 2014 | 36.77M |
| December 31, 2013 | 50.36M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | 263.10M |
| Natera, Inc. | -59.91M |
| Sera Prognostics, Inc. | -8.053M |
| BioRestorative Therapies, Inc. | -2.154M |
| CareDx, Inc. | 19.29M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 202.70M |
| Total Expenses (Quarterly) | 246.60M |
| EPS Diluted (Quarterly) | -0.4587 |
| Enterprise Value | 643.96M |
| Gross Profit Margin (Quarterly) | 64.04% |
| Profit Margin (Quarterly) | -21.66% |
| Earnings Yield | -24.08% |
| Normalized Earnings Yield | -23.01 |